Rebalance’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Rebalance's LLY Position: Q2 2026 in Review
Rebalance increased its Eli Lilly (LLY) stake by 0.89% in Q2 2026, buying an estimated $5.11K and bringing the position to 569 shares worth $682K. The position accounts for 0.04% of the portfolio, ranked #72.
Rebalance first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,640 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Rebalance held 569 shares of Eli Lilly worth $682K as of Q2 2026.
- Rebalance bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
- Eli Lilly made up 0.04% of Rebalance's portfolio in Q2 2026, its #72 holding.
- Rebalance first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- 1,640 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.